| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/2010 | EP2229394A1 Substituted sulfonamide derivatives |
| 09/22/2010 | EP2229393A2 3-substituted-4-oxo-3,4-dihydro-imidazo-[5,1-d][1,2,3,5]-tetrazine-8-carboxylic acid amides as anticancer agents |
| 09/22/2010 | EP2229392A1 Triazolotriazines and triazolopyrazines and their use as gsk3beta inhibitors |
| 09/22/2010 | EP2229390A1 Novel imidazoý1,2-a¨pyridine and imidazoý1,2-b¨pyridazine derivatives |
| 09/22/2010 | EP2229387A1 Process for preparing chemically and chirally pure solifenacin base and its salts |
| 09/22/2010 | EP2229386A1 Aminothiazoles and their uses |
| 09/22/2010 | EP2229385A2 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 09/22/2010 | EP2229383A1 Isoxazolo-pyrazine derivatives |
| 09/22/2010 | EP2229381A1 Gamma secretase modulators |
| 09/22/2010 | EP2229380A1 Polymorphic forms of a 3-pyrrole substituted 2-indolinone |
| 09/22/2010 | EP2229379A2 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 09/22/2010 | EP2229377A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 09/22/2010 | EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 09/22/2010 | EP2229375A1 Gamma secretase modulators |
| 09/22/2010 | EP2229374A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 09/22/2010 | EP2229373A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| 09/22/2010 | EP2229371A1 Cyclic triazo and diazo sodium channel blockers |
| 09/22/2010 | EP2229369A1 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders |
| 09/22/2010 | EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 09/22/2010 | EP2229364A2 Dibenzoazepine and dibenzooxazepine trpa1 agonists |
| 09/22/2010 | EP2229363A1 Renin inhibitors |
| 09/22/2010 | EP2229362A1 Piperazines as anti-obesity agents |
| 09/22/2010 | EP2229361A1 Tetrahydroindoles having sphingosine-1-phosphate receptor activity |
| 09/22/2010 | EP2229358A1 Indoles and their therapeutic use |
| 09/22/2010 | EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/22/2010 | EP2229351A1 Process for the production of 2-ý4-(3- or 2-fluorobenzyloxy)benzylamino¨propanamides with high purity degree |
| 09/22/2010 | EP2229185A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 09/22/2010 | EP2229180A1 Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
| 09/22/2010 | EP2229175A1 Composition and method for dermal regeneration |
| 09/22/2010 | EP2229173A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 09/22/2010 | EP2229172A1 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 09/22/2010 | EP2229171A2 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 09/22/2010 | EP2229170A1 Kinesin inhibitors as cancer therapeutics |
| 09/22/2010 | EP2229169A1 Preparation containing chromane-2-one derivatives |
| 09/22/2010 | EP2229168A1 Pharmaceutical composition for treating malaria |
| 09/22/2010 | EP2229167A1 Mineralocorticoid receptor modulators |
| 09/22/2010 | EP2229165A1 Anti-glycation properties of asicatic acid and madecassic acid |
| 09/22/2010 | EP2229164A1 Elevation of the plasma hdl-cholesterol level |
| 09/22/2010 | EP2229162A2 Substituted benzoquinones and hydroquinones in the treatment of periodontal diseases |
| 09/22/2010 | EP2229155A1 Particles in a capsule |
| 09/22/2010 | EP2229153A2 Coated extended release pharmaceutical compositions of levetiracetam |
| 09/22/2010 | EP2229150A2 Systems and methods for delivery of materials |
| 09/22/2010 | EP2229149A1 Process for recovering flunixin from pharmaceutical compositions |
| 09/22/2010 | EP2229138A1 Topical compositions comprising non-proteogenic amino acids and methods of treating skin |
| 09/22/2010 | EP2229065A1 Smokeless compressed tobacco product for oral consumption |
| 09/22/2010 | EP2229056A1 Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
| 09/22/2010 | EP2229055A1 Method of aralkylation of 4'-hydroxyl group of anthracyclins |
| 09/22/2010 | EP2229053A2 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same |
| 09/22/2010 | EP2134704B1 Compounds and compositions as modulators of gpr119 activity |
| 09/22/2010 | EP2091950B1 Oxadiazole derivatives as s1p1 receptor agonists |
| 09/22/2010 | EP2076506B1 Heterocyclic-substituted piperidines as orl-1 ligands |
| 09/22/2010 | EP2050454B1 Moisturizing agent |
| 09/22/2010 | EP2044078B1 Camptothecin derivatives with antitumor activity |
| 09/22/2010 | EP2029552B1 Sulfimides as protein kinase inhibitors |
| 09/22/2010 | EP2021330B1 Benzimidazole modulators of vr1 |
| 09/22/2010 | EP1978967B1 Quinazolinone derivatives as vanilloid antagonists |
| 09/22/2010 | EP1913004B1 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 09/22/2010 | EP1896477B1 Aspartyl protease inhibitors |
| 09/22/2010 | EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/22/2010 | EP1812440B1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases |
| 09/22/2010 | EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 09/22/2010 | EP1799643B1 Indolone derivatives, processes for preparing them and their uses |
| 09/22/2010 | EP1796669B1 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/22/2010 | EP1786766B1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 09/22/2010 | EP1773791B1 Pyrrolotriazine compounds |
| 09/22/2010 | EP1765830B1 Mitotic kinesin inhibitors |
| 09/22/2010 | EP1730135B1 Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc) |
| 09/22/2010 | EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/22/2010 | EP1682549B1 Imidazo[1,2-a]pyridine anxiolytics |
| 09/22/2010 | EP1620399B1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 09/22/2010 | EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 09/22/2010 | EP1617803B1 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 09/22/2010 | EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2. |
| 09/22/2010 | EP1490374B1 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |
| 09/22/2010 | EP1401853B1 Modulators of pharmacological agents |
| 09/22/2010 | EP1194449B1 Inhibitors of memapsin 2 and use thereof |
| 09/22/2010 | EP1147086B9 Compositions for the treatment of skin diseases |
| 09/22/2010 | CN201586232U Vitamin C fructus forsythiae soft capsule |
| 09/22/2010 | CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 09/22/2010 | CN1947722B Blood sugar regulator used during user having meals and its preparation method |
| 09/22/2010 | CN1943755B A Chinese traditional medicinal composition for treatment of hypertension and its preparation method |
| 09/22/2010 | CN1943726B A Chinese traditional medicinal composition for treatment of ischemic apoplexy and its preparation method |
| 09/22/2010 | CN1911016B Synergistic microbicidal combination |
| 09/22/2010 | CN1863799B Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 09/22/2010 | CN1856484B Therapeutic agents useful for treating or preventing pain |
| 09/22/2010 | CN1852708B Human beta-defensin secretion promoter |
| 09/22/2010 | CN1813782B Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof |
| 09/22/2010 | CN1805729B Nasal pharmaceutical formulations and methods of using the same. |
| 09/22/2010 | CN1788001B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/22/2010 | CN1658872B Antiallergic |
| 09/22/2010 | CN101842488A Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 09/22/2010 | CN101842483A Rna antagonist compounds for the modulation of beta-catenin |
| 09/22/2010 | CN101842478A Compositions for treating multiple sclerosis |
| 09/22/2010 | CN101842392A Non-anticoagulant polysaccharide compositions |
| 09/22/2010 | CN101842380A Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material |
| 09/22/2010 | CN101842378A Phosphadiazine HCV polymerase inhibitors IV |
| 09/22/2010 | CN101842377A Dispiro 1,2,4-trioxolane antimalarials |
| 09/22/2010 | CN101842376A Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 09/22/2010 | CN101842374A 2,3-substituted azaindole derivatives for treating viral infections |